Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 2, 2013
Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trialYiping Chen, Yueyi Deng, Zhaohui Ni, et al.Kidney International|January 20, 2012
Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failureYifei Zhong, Yingwei Wu, Ruijie Liu, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|June 14, 2013
The Application of SILAC Mouse in Human Body Fluid Proteomics Analysis Reveals Protein Patterns Associated with IgA NephropathyShilin Zhao, Rongxia Li, Xiaofan Cai, et al.Annals of Palliative Medicine|January 12, 2022
A multicenter study of hemodialysis using individualized dialysate potassium concentrationsHaidong He, Jiajun Wu, Wei Lu, et al.Trials|June 7, 2013
The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trialHui Wang, Wei Mu, Jingbo Zhai, et al.Endocrine|November 23, 2015
Elevated plasma tumor necrosis factor-α receptor 2 and resistin are associated with increased incidence of kidney function decline in Chinese adultsGang Liu, Yueyi Deng, Liang Sun, et al.Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2018
Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration RateFeijie Wang, Liang Sun, Qi Sun, et al.Environment International|April 19, 2026
Plasma exposome and proteome revealed the role of polycyclic aromatic hydrocarbons in chronic kidney diseasesXiaoshan Zhou, Weitian Deng, Chengshuang Chu, et al.Renal Failure|August 16, 2021
Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trialZhaohui Ni, Zhen Zhang, Zanzhe Yu, et al.Journal of the American Society of Nephrology : JASN|April 6, 2013
Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylaseYifei Zhong, Edward Y Chen, Ruijie Liu, et al.Pageof 5